Identify a company's funding phase, sum & investors
Input company URLs and names to get complete funding history from Crunchbase with total amounts, round details, and investor lists, plus automated web research for recent funding events including stage, sum, lead investors, and deal summaries.
Template Preview
22 columns1 source
Crustdata
Crustdata| Company URL | Company name | Logo | Company name | Website | Total amount raised | # Investors | # Funding rounds | Last funding date | Investors | Investments | Latest round details | Date | Amount | Latest Round | Lead Investor | AI researcher | Stage | Amount | Lead | Investors | Summary |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| auditboard.com | AuditBoard | https://images.crunchbase.com/image/upload/c_pad,h_256,w_256,f_auto,q_auto:eco,dpr_1/jgztbuz2f5vyf7dj6541 | AuditBoard | https://www.auditboard.com | 214386244 | 5 | 4 | 2025-01-02T00:00:00Z | 9 items | 0 items | {"result":{"Date":"Not specified","Amount":"Not specified","Latest Round":"Series B","Lead Investor":"Battery Ventures"}} | Not specified | Not specified | Series B | Battery Ventures | {"Lead":"Battery Ventures (last venture funding, 2018)","Stage":"Series B (2018, prior to acquisition)","Amount":"$40 million (Series B, 2018); $43.6 million total venture funding; Acquired by Hg for over $3 billion in 2024","Result":"AuditBoard was acquired by Hg in May 2024 for over $3 billion; no recent venture funding prior to acquisition, last funding round was Series B in 2018","Summary":"AuditBoard's most recent capital raise was a Series B funding round of $40 million in August 2018, led by Battery Ventures, bringing its total venture funding to $43.6 million. Since then, AuditBoard focused on organic growth, surpassing $200 million in ARR by 2024, at which point it was acquired by Hg for over $3 billion. The acquisition aims to fuel AuditBoard’s global expansion and product innovation, leveraging Hg’s software expertise to accelerate AuditBoard's leadership in the audit, risk, and compliance sectors.","Investors":"Battery Ventures (Series B lead), Act One Ventures, Mucker Capital, Wavemaker Partners","Reasoning":"No evidence of a recent venture capital round after 2018 per AuditBoard’s official site and third-party reports. The acquisition by Hg in May 2024 is the latest significant capital event, validating the company’s rapid growth and industry leadership."} | Series B (2018, prior to acquisition) | $40 million (Series B, 2018); $43.6 million total venture funding; Acquired by Hg for over $3 billion in 2024 | Battery Ventures (last venture funding, 2018) | Battery Ventures (Series B lead), Act One Ventures, Mucker Capital, Wavemaker Partners | AuditBoard's most recent capital raise was a Series B funding round of $40 million in August 2018, led by Battery Ventures, bringing its total venture funding to $43.6 million. Since then, AuditBoard focused on organic growth, surpassing $200 million in ARR by 2024, at which point it was acquired by Hg for over $3 billion. The acquisition aims to fuel AuditBoard’s global expansion and product innovation, leveraging Hg’s software expertise to accelerate AuditBoard's leadership in the audit, risk, and compliance sectors. |
| next-health.com | Next Health | https://images.crunchbase.com/image/upload/c_pad,h_256,w_256,f_auto,q_auto:eco,dpr_1/v1397193818/65b11a573d8a0e8434627c0b7dd46d2a.jpg | Next Health | http://www.nexthealthinc.com | 100000 | 1 | 2012-04-25T00:00:00Z | 0 items | 0 items | {"result":{"Date":"March 2024","Amount":"$25M","Latest Round":"Series B","Lead Investor":"Accel Partners"}} | March 2024 | $25M | Series B | Accel Partners | {"Lead":"Mucker Capital","Stage":"Other/Undisclosed (most recent round labeled as 'Other Investors')","Amount":"Not disclosed","Result":"No specific amount or funding round type (e.g., Seed, Series A/B) is disclosed for the latest round in public databases or industry news.","Summary":"Next Health is a health optimization center founded by Dr. Darshan Shah, operating in the US and Dubai, offering hormone therapy, wellness technology, and advanced medical services. The company’s most recent known fundraising round is listed as 'Other Investors,' with Mucker Capital, M13, and For Good Ventures among backers. However, there are no public details on the round’s size or its date. There is no publicly available announcement describing the use of funds, strategic priorities, or growth plans tied specifically to this most recent investment.","Investors":"Mucker Capital, M13, For Good Ventures","Reasoning":"The official Next Health website and resources do not provide any recent funding announcements. Secondary and database sources, such as CB Insights, confirm a recent funding status as 'Other Investors' with Mucker Capital, M13, and For Good in the investor list, but do not disclose round type or amount. There are no public press releases or third-party coverage describing the investment amount, date, or intended use, so no speculative details can be provided."} | Other/Undisclosed (most recent round labeled as 'Other Investors') | Not disclosed | Mucker Capital | Mucker Capital, M13, For Good Ventures | Next Health is a health optimization center founded by Dr. Darshan Shah, operating in the US and Dubai, offering hormone therapy, wellness technology, and advanced medical services. The company’s most recent known fundraising round is listed as 'Other Investors,' with Mucker Capital, M13, and For Good Ventures among backers. However, there are no public details on the round’s size or its date. There is no publicly available announcement describing the use of funds, strategic priorities, or growth plans tied specifically to this most recent investment. | |
| servicetitan.com | ServiceTitan | https://images.crunchbase.com/image/upload/c_pad,h_256,w_256,f_auto,q_auto:eco,dpr_1/705b4b8b7bdc415988c51204bb239e02 | ServiceTitan | http://www.servicetitan.com | 1464777129 | 20 | 10 | 2022-11-10T00:00:00Z | 10 items | 0 items | {"result":{"Date":"Not specified","Amount":"Not specified","Latest Round":"Series H","Lead Investor":"Not specified"}} | Not specified | Not specified | Series H | Not specified | {"Lead":"Goldman Sachs (IPO lead underwriter). For latest private round: no single lead disclosed publicly; July 2023 H-1 primary/tender priced at $72.50 per share per S-1 analysis.","Stage":"IPO (most recent completed capital raise). Prior latest private round: Series H-1 (July 2023).","Amount":"~$625 million gross IPO proceeds from selling 8.8 million shares at $71 per share in December 2024[3]. Prior private round: $34 million primary (Series H-1) plus $136 million employee tender in July 2023, total $170 million transaction value at blended $72.50/share[1].","Result":"Company listed on Nasdaq under ticker TTAN in Dec 2024; opened at $101, market cap ~$9 billion; stock settled over $100 in early 2025 analysis[3][6].","Summary":"Most recent capital raise was the December 2024 IPO, led by Goldman Sachs as lead banker, issuing 8.8 million new shares at $71 for roughly $625 million in proceeds to fund growth as a public company[3]. An earlier July 2023 Series H-1 added ~$34 million of primary capital and facilitated a $136 million employee liquidity tender at a blended $72.50/share, preceding the IPO[1]. Strategic priorities around earlier large private rounds included scaling product, customer experience, hiring, and growth, as noted when the company raised $500 million in 2021[2].","Investors":"IPO buyers (public market investors); underwriters led by Goldman Sachs. Earlier investors include Tiger Global, Sequoia Capital Global Equities, H.I.G. Growth Partners, Arena Holdings, Battery Ventures, Bessemer Venture Partners, Dragoneer, Durable Capital Partners, ICONIQ Growth, Index Ventures, and T. Rowe Price funds (from 2021 round)[2].","Reasoning":"Primary source on latest round is IPO coverage with specific share count, price, and proceeds; corroborated by post-IPO analyses. Meritech’s S-1 breakdown provides details on the 2023 Series H-1 primary and tender."} | IPO (most recent completed capital raise). Prior latest private round: Series H-1 (July 2023). | ~$625 million gross IPO proceeds from selling 8.8 million shares at $71 per share in December 2024[3]. Prior private round: $34 million primary (Series H-1) plus $136 million employee tender in July 2023, total $170 million transaction value at blended $72.50/share[1]. | Goldman Sachs (IPO lead underwriter). For latest private round: no single lead disclosed publicly; July 2023 H-1 primary/tender priced at $72.50 per share per S-1 analysis. | IPO buyers (public market investors); underwriters led by Goldman Sachs. Earlier investors include Tiger Global, Sequoia Capital Global Equities, H.I.G. Growth Partners, Arena Holdings, Battery Ventures, Bessemer Venture Partners, Dragoneer, Durable Capital Partners, ICONIQ Growth, Index Ventures, and T. Rowe Price funds (from 2021 round)[2]. | Most recent capital raise was the December 2024 IPO, led by Goldman Sachs as lead banker, issuing 8.8 million new shares at $71 for roughly $625 million in proceeds to fund growth as a public company[3]. An earlier July 2023 Series H-1 added ~$34 million of primary capital and facilitated a $136 million employee liquidity tender at a blended $72.50/share, preceding the IPO[1]. Strategic priorities around earlier large private rounds included scaling product, customer experience, hiring, and growth, as noted when the company raised $500 million in 2021[2]. |
Similar templates
View all →
Start enriching your data in minutes
Connect to 160+ data providers. No credit card required.